TLP Group’s ResMed RMD Stock Holding History

TLP Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-464	Closed	-$54K	–	322
2018 Q3	$54K	Sell	464 -259	-36%	-$28.4K	0.09%	129
2018 Q2	$75K	Buy	+723	New	+$73.2K	0.11%	126
2017 Q4	–	Sell	-194	Closed	-$15K	–	707
2017 Q3	$15K	Buy	+194	New	+$14.8K	0.01%	314
2016 Q1	–	Sell	-5,774	Closed	-$310K	–	387
2015 Q4	$310K	Buy	+5,774	New	+$325K	0.25%	119

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TLP Group's RMD Position: Q4 2018 in Review

TLP Group sold out of ResMed (RMD) in Q4 2018, closing a stake of 464 shares — an estimated $54K sold.

TLP Group first reported a position in RMD in Q4 2015 and held it in 4 quarters. The position peaked at $310K in Q4 2015. 501 funds tracked by Wall St. Rank hold RMD as of Q4 2018.

TLP Group reported no remaining ResMed position as of Q4 2018 after selling out during the quarter.
TLP Group sold 464 ResMed shares in Q4 2018, an estimated $54K.
TLP Group first reported a position in ResMed in Q4 2015 and held it in 4 quarters.
TLP Group's ResMed position peaked at $310K in Q4 2015.
501 funds tracked by Wall St. Rank held ResMed as of Q4 2018.

Based on TLP Group's 13F filing for Q4 2018, filed 14 Feb 2019.